K-numberK243591
Device nameOPTOVISION Endoscopic Light Source Unit
ApplicantOptosurgical, LLC
Product codeOWN
Device classClass II
Decision dateFeb 19, 2025
DecisionSubstantially Equivalent
Regulation876.1500
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The OPTOVISION Endoscopic Light Source Unit is a medical device that provides real-time endoscopic visible light and near-infrared fluorescence imaging during minimally invasive surgical procedures. When used with indocyanine green (ICG) dye administered intravenously, it enables surgeons to visualize blood vessels, tissue perfusion, and bile ducts; when ICG is administered interstitially, it visualizes the lymphatic system including lymph nodes and vessels.

Technological characteristics

The subject device uses RGB LEDs and an 808nm infrared laser diode combined through dichroic mirrors and projected onto an output light collimator, with fiber coupling to an endoscope. The predicate uses the same RGB LEDs and infrared laser approach but at 806nm and 830nm wavelengths. Both employ electronic drivers for light control. The subject device offers imaging modes (NIR, VIS, FUSION) where the FUSION mode functionally equates to the predicate's Overlay mode and NIR mode equates to Contrast mode, though the subject lacks the ENV mode.

Test standards cited

IEC 60601-1 (electrical safety), IEC 60601-2-18 (endoscope standards), IEC 60601-1-2 (electromagnetic compatibility), IEC 62471 (photobiological safety), IEC 62366-1 (usability), and IEC 62304 (software validation and verification).

Substantial equivalence argument

Both devices share identical intended use for ICG-based near-infrared fluorescence imaging of vessels, bile ducts, and lymphatic structures during endoscopic surgery. The minor technological differences—808nm versus 806nm/830nm wavelengths and different imaging mode nomenclature—do not affect primary function since both wavelengths perform equivalent NIR fluorescence imaging with ICG, and the subject's imaging modes functionally replicate the predicate's capabilities. All performance testing demonstrated compliance with applicable safety standards with no safety concerns identified, establishing that the devices are functionally equivalent despite minor technical variations.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →